Stock screener

GSK

Conviction 43HealthcareScan · Mon, Aug 10, 2026
GSK$52.19-1.45%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 4.48M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +200.00%· 3 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
GSK plcDrug Manufacturers - Generalwww.gsk.com ↗
Price52.19
Change-1.45%
Gap-2.76%
Rel volume0.43×
Avg volume4.64M
Avg $ vol240.75M
SMA 2051.77
SMA 5051.76
SMA 20051.85
Price vs 50+0.83%
Price vs 200+0.66%
MA stackmixed
50/200 crossdeath · 3d
Supertrenddown · 53.91
RSI (14)51
MACD hist0.06
MACD crossbull · 2d
Stoch %K / %D39 / 43
ADX (14)11
+DI / −DI29 / 26
RSI divergence—
MACD divergence—
ATR %+2.33%
ADR %1.98%
52w high61.18
52w low37.71
From 52w high-14.69%
Above 52w low+38.40%
New 52w highNo
SqueezeOff
Bollinger width6.82%
%B0.62
Donchian pos39.02%
Donchian high55.79
Donchian low49.89
AVWAP (52w high)53.62
vs AVWAP high-2.68%
AVWAP (52w low)49.92
vs AVWAP low+4.55%
OBV trendFlat
Chaikin MF (20)-0.12
Today vs 20d0.43×
Avg vol (14d)4.48M
Avg vol (20d)4.64M
Avg $ vol (20d)240.75M
Market cap225.22B
RS 3m (vs SPY)-0.83%
RS 6m (vs SPY)-24.61%
RS line new highNo
Trend template5/8
Technical rank37.4
1 week+1.32%
1 month-1.12%
3 months+3.53%
6 months-13.35%
1 year+38.88%
YTD+5.16%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target68.55
Target upside31.35%
Analyst ratingBuy
Institutional18.61%
Ent. value225.22B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDrug Manufacturers - General
ExchangeNYSE
Shares out2.03B
Employees66.84K
ListedWed, Aug 18, 1976
Free float1.81B
Float %90.3%
Short interest13.76M
Days to cover4.5d
Short volume40.1%
Squeeze score24 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.36 vs $1.27
Last surprise+7.1% beat
Setup gradeD
Conviction43 / 100
Pattern quality—
Tech rank37.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance55.04
Support50.11
Days since event—
Candle confirm—
News sentiment—

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jun 23 – Jul 13
    2 scans
  2. Breaking out now
    Jul 28
    1 scan

Congress activity

Disclosed STOCK Act trades in GSK · 10 recent

All disclosures →
MemberSideAmount
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-31
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-30
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2025-09-23
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2024-11-18
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-08-04
Buy$1K–$15K
Robert B. Aderholt
Robert B. Aderholt
house · R · AL · traded 2025-07-28
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-24
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-17
Buy$1K–$15K
Bruce Westerman
Bruce Westerman
house · R · AR · traded 2025-04-21
Sell$1K–$15K
Bruce Westerman
Bruce Westerman
house · R · AR · traded 2025-03-03
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in GSK

No recent insider (Form 4) filings in GSK. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GSK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.